Detalles de la búsqueda
1.
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese females.
J Cell Biochem
; 120(7): 12039-12050, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30805963
2.
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Oncologist
; 22(12): 1431-1443, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28912152
3.
Clinical and pathological portraits of axillary presentation breast cancer and effects of preoperative systemic therapy.
Chin J Cancer Res
; 29(4): 369-373, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28947869
4.
A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.
Chin J Cancer Res
; 29(4): 351-360, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28947867
5.
Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy.
Tumour Biol
; 37(4): 4873-81, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26526577
6.
[Predictive factors of pathological complete response in primary human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy].
Zhonghua Wai Ke Za Zhi
; 54(2): 94-8, 2016 Feb 01.
Artículo
en Zh
| MEDLINE | ID: mdl-26876074
7.
Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 154(2): 239-49, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26498019
8.
[Clinicopathological features of Luminal B-like breast cancer].
Zhonghua Yi Xue Za Zhi
; 95(4): 248-51, 2015 Jan 27.
Artículo
en Zh
| MEDLINE | ID: mdl-25877237
9.
[Re-evaluation of HER2 status in 1 501 invasive breast cancers according to the 2013 American Society of Clinical Oncology/College of American Pathology guidelines].
Zhonghua Bing Li Xue Za Zhi
; 44(1): 42-7, 2015 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-25765030
10.
[Neoadjuvant treatment in human epidermal growth factor receptor 2-positive breast cancer].
Zhonghua Wai Ke Za Zhi
; 53(12): 901-4, 2015 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-26850663
11.
[Analysis on clinical and pathological characteristics of 66 patients with stage IV breast cancer].
Zhonghua Wai Ke Za Zhi
; 53(12): 935-40, 2015 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-26850666
12.
[Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study].
Zhonghua Yi Xue Za Zhi
; 94(26): 2018-21, 2014 Jul 08.
Artículo
en Zh
| MEDLINE | ID: mdl-25312661
13.
[Study on clinicopathological classification and clinical and pathological characteristics in breast cancer].
Zhonghua Wai Ke Za Zhi
; 52(2): 113-6, 2014 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-24809519
14.
[Analysis of detecting value of ultrasound and the clinic-pathological features of axillary metastasis in breast cancer].
Zhonghua Wai Ke Za Zhi
; 52(12): 924-8, 2014 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-25622584
15.
[Effects of vinorelbine plus cisplatin as second-line neoadjuvant chemotherapy regimen in the treatment of breast cancer].
Zhonghua Yi Xue Za Zhi
; 93(2): 93-5, 2013 Jan 08.
Artículo
en Zh
| MEDLINE | ID: mdl-23648342
16.
[Analysis of intraoperative molecular assessment of sentinel lymph nodes in breast carcinoma].
Zhonghua Wai Ke Za Zhi
; 51(2): 135-8, 2013 Feb 01.
Artículo
en Zh
| MEDLINE | ID: mdl-23711006
17.
[Factors related with pathological complete response of neoadjuvant chemotherapy in primary breast cancer].
Zhonghua Wai Ke Za Zhi
; 51(4): 339-43, 2013 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-23895756
18.
[A study on the predictive and evaluational value of molecular subtypes and dynamic contrast-enhanced magnetic resonance imaging of neoadjuvant chemotherapy for breast cancer].
Zhonghua Wai Ke Za Zhi
; 51(8): 706-9, 2013 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-24252676
19.
Breast Cancer Awareness and Association with Frequency of Screening Among Women - China, 2020.
China CDC Wkly
; 5(15): 327-332, 2023 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37193085
20.
A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expression.
Chin Med J (Engl)
; 136(24): 2967-2973, 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822006